May Measurement Month 2023: an analysis of blood pressure screening results from Argentina
Clicks: 3
ID: 318911
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #212 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract High blood pressure (BP) is one of the main risk factors for cardiovascular disease with a high prevalence in the adult population despite advances in its diagnosis and treatment. In accordance with the May Measurement Month (MMM) campaign, BP screening was conducted in 2023 by the Argentina Society of Arterial Hypertension (SAHA), to raise awareness of raised BP. This article reports the results of the campaign. A voluntary cross-sectional survey was conducted in public spaces and health centres from May to September 2023. Volunteer adults aged ≥18 years were recruited through convenience sampling. Two BP readings were taken in each participant, and a questionnaire completed collecting information on demographics, lifestyle factors, and comorbidities. Multiple imputation was used to estimate missing BP readings. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90mmHg, or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. In total, 39,391 were screened, with a mean age of 57.5 years and 63.4% of whom were female. Of all participants, 24,777 (62.9%) had hypertension, of whom 21,044 (84.9%) were aware, and 20,775 (83.8%) were on antihypertensive medication. Of those on antihypertensive medication, 11,642 (56.0%) had control, and of all participants with hypertension, 47.0% had controlled BP. The MMM campaign in Argentina identified a substantial number of participants with untreated but more frequently inadequately treated hypertension. BP control has not significantly improved over the years. It is essential to implement more effective strategies, such as treatment adjustments, lifestyle changes, and close patient monitoring, to improve control and reduce long-term risks.
| Reference Key |
openalex_W7166072169
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Judith Zilberman, Thomas Beaney, Gabriele Kerr, Pedro A. Villezca Becerra, Fortunato García Vásquez, Cristina Rojas, Pablo Irusta, Mariana Fita, Evangelina Marissi, José Cardozo, Arnoldo Kalbermatter, Ana Catarina Lagos, Analía Fuentes, Marcos J. Marín |
| Journal | European heart journal supplements : journal of the European Society of Cardiology |
| Year | 2026 |
| DOI |
10.1093/eurheartjsupp/suag082
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.